Yabao Pharmaceutical Group Co. Ltd. Class ASSE: 600351

Announcement on Termination of Clinical Trials for Research Projects and the Provision of Impairment Provisions

· Issued by Yabao Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Termination of Clinical Trials for Research Projects and the Provision of Impairment Provisions

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis